Prof. Katapodi has more than 15 years’ experience caring for families affected by hereditary cancer. She is interested in how individuals make decisions about genetic testing and cancer screening, how they cope with hereditary cancer, and in increasing public awareness about use of genetic services.

Dr. Souria AISSAOUI has a doctorate degree in onco-genetic counseling and predictive medicine and 15 years of experience. She was trained at the Hospices Civils de Lyon, Marseille and Paris. Since 2019, she is a Collaborator and Manager of the onco-genetic consultation of Genesupport (Switzerland) in the Geneva and Fribourg areasand an active member of the Tumorboard.

Murat Aykut, PhD works as a Clinical Research Coordinator at Kantonsspital Winterthur, Department of Medical Oncology & Hematology. He is part of the recruitment team for the CASCADE and DIALOGUE studies at the Department of Clinical Research, Faculty of Medicine at the University of Basel. He holds a PhD degree in Cancer Biology from the University of Zurich and he is actively involved in the clinical research since 2015. His scientific interest focuses on hereditary cancers, immunotherapy in solid tumors and hematological diseases.

Ms. Arianna Elena Maria Bonfanti is a scientific associate in the Department of Medical Genetics at Spital Wallis (Hôpital du Valais) in Sion, Switzerland. She provides expert genetic consultations and spearheading research initiatives within the institution.

Dre. Fulvia Brugnoletti is a clinical geneticist in the Oncogenetics and Cancer Prevention Unit at the Hôpitaux Universitaires de Genève, where she focuses on the genetic aspects of cancer and strategies for its prevention. Her work involves researching genetic predispositions to cancer, providing genetic counseling, and developing prevention strategies for individuals at high risk.

PD Dr. Nicole Bürki is in charge of the “Genetic counseling for familial breast and ovarian cancer” at the University Hospital in Basel since June 2013. She is an active member of the “Network for Cancer Predisposition Testing and Counseling” of the Swiss Group for Clinical Cancer Research (SAKK) and the SAKK Breast Cancer Group.

Prof. Dr. Maria Caiata-Zufferey is Professor in the Social and Health Sciences at the Department of Business Economics, Health and Social Care (DEASS) of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI), and the head of the Competence Center for Healthcare Practices and Policies. She holds a PhD in social sciences from the University of Fribourg, Switzerland. In the field of genetics, she is particularly interested in how women manage the uncertainty related to their genetic predisposition to cancer, and in the role of communication in this situation.

Prof. Dr. Pierre Chappuis is onco-geneticist and was responsible for the Breast Center at the Hôpitaux Universitaire Genève (HUG), Switzerland. Pierre Chappuis was managing the HUG Breast Center, which opened in 2011 and since 2014 benefits from the quality label assigned to it by the Swiss Cancer League and the Swiss Senology Society. He was responsible for the oncogenetics program at the hospital, which focuses on onco-genetic consultations and a multidisciplinary consensus.

Muriel Fluri works as an Advanced Practice Nurse in genetic counselling at the Clinic of Medical Oncology, University Hospital of Bern, Inselspital and as a research assistant for the CASCADE study at the Department of Clinical Research, Faculty of Medicine at the University of Basel. She holds a Master of Science degree in Nursing from the University of Applied Sciences Bern. She is interested in how people with a confirmed genetic predisposition to cancer can be better cared for by an Advanced Practice Nurse.

Dr. Rossella Graffeo is a senior medical oncologist at the Istituto Oncologico della Svizzera Italiana (IOSI) and the director of the oncogenetics service at the division of medical genetics. Her main clinical and research interests focus on breast cancer and genetic risk evaluation in young women.

Prof. Dr. Karl Heinimann is a Professor of Medical Genetics at the University Hospital in Basel and the Department of Biomedicine at the University of Basel, Switzerland.
Prof. Dr. Karl Heinimann has more than 15 years of experience in genetic counseling and genetic testing of patients and families with a predisposition to cancer. His main interest lies in researching the genetic basis of hereditary cancer and the molecular changes in these tumors.

Prof. Dr. Viola Heinzelmann-Schwarz is a specialist in gynecological oncology and the director of the gynecological clinic at the University Hospital Basel. She has been trained in Tübingen, London (UCL), Dunedin / New Zealand and completed her training as a gynecologist at the University of Zurich, where she received her Venia Legendi (Privatdozentur) in 2007. From 2008 to 2012 she was sub-specialized in one of Australia’s largest gynecological cancer centers in Sydney. Her clinical and scientific focus is on gynecological carcinomas, especially ovarian cancer.

Professor Su Kim has more than 20 years of experience in the fields of women’s health nursing and women’s cancer. Her research uses both qualitative and mixed research methods. She conducted an RCT examining the efficacy of an exercise maintenance program designed for breast cancer survivors experiencing fatigue and returning to work. Professor Sue Kim is interested in improving cancer survival of breast and ovarian cancer patients, and especially improving family adjustment. The K-CASCADE international collaborative research is being conducted with the support of the National Research Foundation of Korea and the Swiss Research Foundation.

Dr. Helen Koechlin is a research group leader at the University Children’s Hospital Zurich. She holds a PhD in Clinical Psychology from the University of Basel. Her research focuses on the prevention and treatment of chronic pain in children and adolescents and emotion-related factors. She is also interested in other topics in the field of child and adolescent psychology, specifically the well-being of children of critically ill parents.

Ms. Lena Köver, MBA assists with the successful implementation of the CASCADE cohort, including regulatory compliance, and collaboration with partners to advance research goals. Lena also contributes to project sustainability through strategic grant writing, and manages communications and events for project visibility. Lena holds a BA and MSc in Social Sciences from the University of Oxford and an MBA in International Health Management. Prior to joining the University of Basel in 2021, Lena managed international projects across the private, public, and non-profit sectors.

Dre. Camille Kumps is affiliated with the Service de Médecine Génétique at the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland.
She has an FMH in genetics and has been responsible for the oncogenetics consultations since April 2023. She is also a member of the Network for Cancer Predisposition Testing and Counseling of the Swiss Group for Clinical Cancer Research (SAKK).

Ms. Elena Corina Luca is a nurse researcher at the Oncologic Institute of Southern Switzerland – Ente Ospedaliero Cantonale (Istituto Oncologico della Svizzera Italiana | EOC) and head of nursing research at the Regional Hospital of Lugano, Ente Ospedaliero Cantonale (Ospedale Regionale di Lugano | EOC). She is also a lecturer at the University of Applied Sciences and Arts of Southern Switzerland in the Master of Science in Nursing Program (Master of Science in Cure infermieristiche – SUPSI).

Dr. Christian Kurzeder is the leader of the Breast Center, Head Physician of Senology and Deputy Head Physician of Gynaecologic Oncology at the University Hospital in Basel, Switzerland. He is a member of the PHB Oncology Cluster, a multidisciplinary center for translational research in Personalized Health medicine in the cancer field. He focuses on oncoplastic breast conserving surgery in connection to the treatment of breast cancer.

Ashley Machen is a Breast Cancer and Prostate Cancer Nurse Specialist at the Hirslanden Clinique des Grangettes. She is also the Administrative Director and Clinical Trial Coordinator for both the Breast Cancer and Prostate Cancer centers. She holds a Bachelor of Science in Nursing (BSN) from the University of Louisiana at Monroe (ULM) and a Bachelors of Arts (BA) in International Business and French from Eckerd College in St. Petersburg, Florida USA. She is interested in understanding how patients with a cancer diagnosis manage their increased risk of further cancers after discovering they carry a pathogenic variant.

Dr. Chang Ming is a senior biostatistician with over a decade of experience in clinical research, specializing in biostatistics, epidemiology, and real-world evidence across oncology and other therapeutic areas. His current work with the CASCADE Consortium focuses on leveraging advanced statistical methodologies, including machine learning-based cancer risk prediction and cancer survival prediction models, to enhance patient outcomes.

Dr. Christian Monnerat is the head physician of the Oncology Unit of the Hôpital du Jura, where he also provides oncogenetic consultations. In 1997, he obtained his FMH title of Internal Medicine and his doctorate in medicine in 1998 with the Prize of the Faculty of Medicine of Lausanne. In 1999, he obtained his FMH title of medical oncology. In 2001, he won the European University Diploma in Clinical Research in Cancerology from the University of Paris XI and the Institut Gustave-Roussy, as well as the Master of Genetics with mention of the University of Paris V and the Hôpital Necker-Enfants malades.

Prof. Dr. Carla Pedrazzani has a PhD in Nursing Science from the Faculty of Medicine at the University of Basel. She is the Director of the Undergraduate Nursing Program at the Department of Business Economics, Health and Social Care (DEASS) of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI). She holds a Master of Science degree in Nursing from University of Turin, Italy. She is interested in oncology nursing,communication in hereditary cancers, and genetic nursing practice.

Prof. Dr. Nicole Probst-Hensch is the Head of the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute (Swiss TPH) and Professor in Epidemiology and Public Health at the Medical Faculty of the University of Basel, Switzerland. She holds doctorates in pharmaceutical sciences and in epidemiology. She established and was the first director of the National Institute of Cancer Epidemiology and Registration (NICER). At Swiss TPH, Nicole Probst-Hensch is responsible for the group working on Genetic Epidemiology of Non-Communicable Diseases.

Dr. Manuela Rabaglio is senior physician at the Clinic of Medical Oncology, University Hospital of Bern, Inselspital where she is also head of the Quality Assurance Clinical Trial Unit. Manuela Rabaglio is the head of medical affairs at IBCSG, Bern and she received her professional qualifications in Switzerland and Portugal. Her current focus lies on genetic counseling and cancer prevention for breast cancer, gynecological tumors and other hereditary cancer syndromes.

Dr. Sandra Schmid is a consultant medical oncologist at the Cantonal Hospital of Lucerne and Cantonal Hospital of Uri. She focuses on the detection of hereditary cancers, especially Lynch Syndrome and other hereditary gastrointestinal and urological cancers. She provides genetic consultations to patients with a germline pathogenic variant and their families regarding cancer prevention and risk management.

Dr. Catrina Uhlmann Nussbaum is a senior physician affiliated with the Oncology Center at the Cantonal Hospital in Olten, Switzerland and a Core Team Member of the Breast Center Mittelland. She focuses on the diagnosis and treatment of patients with breast or gynecological cancers. Furthermore, she is a certified genetic and genomic cancer risk assessment (GCRA) specialist. Her research in medical oncology mainly focuses on clinical trials.

Prof. Dr. Simon Wieser is a Professor for Health Economic at ZHAW and leads the health economic research team since 2006. His main research interests include the assessment and decomposition of healthcare spending, health economic evaluations, and the development of prospective payment systems.

Dr. Ursina Zürrer is a senior physician for medical oncology at the Winterthur Cantonal Hospital, Head of the Genetic Counseling Clinic, and member of the management board of the Breast Center and the Gynecological Tumor Center. Her scientific interests lie in the detection of hereditary cancers and how this knowledge influences the treatment of affected patients and cancer prevention in the family. She is also actively involved in research into new or tailored oncological treatments for breast and gynecological tumors.